TipRanks
Sanofi (DE:SNW2)
FRANKFURT:SNW2
Germany Market
SNW2
Sanofi
RESEARCH TOOLSreports

Sanofi (SNW2) Stock News & Sentiment

1 Followers
Sanofi’s Teplizumab Study Signals a New Front in Pediatric Type 1 Diabetes
Premium
Company Announcements
Sanofi’s Teplizumab Study Signals a New Front in Pediatric Type 1 Diabetes
9d ago
SNY
Sanofi’s Chinese Pediatric Meningococcal Vaccine Trial Advances, Sharpening Long-Term Growth Prospects for SNY
Premium
Company Announcements
Sanofi’s Chinese Pediatric Meningococcal Vaccine Trial Advances, Sharpening Long-Term Growth Prospects for SNY
16d ago
SNY
Sanofi Targets Teen Acne With New mRNA Vaccine Trial, Opening a Fresh Growth Avenue for SNY
Premium
Company Announcements
Sanofi Targets Teen Acne With New mRNA Vaccine Trial, Opening a Fresh Growth Avenue for SNY
20d ago
SNY
Sanofi Strikes Strategic Deal With Cheplapharm to Hand Over 20 Mature Medicines and Three Plants
Premium
Company Announcements
Sanofi Strikes Strategic Deal With Cheplapharm to Hand Over 20 Mature Medicines and Three Plants
21d ago
6K
SNY
Sanofi Targets Senior Respiratory Risk With New Phase 2b RSV+HMPV Vaccine Trial
Premium
Company Announcements
Sanofi Targets Senior Respiratory Risk With New Phase 2b RSV+HMPV Vaccine Trial
22d ago
SNY
Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials
Premium
Market News
Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials
1M ago
NVS
SNY
Sanofi: Balanced Risk-Reward as Pipeline Setbacks and Dupixent LOE Temper Growth Outlook, With BD/M&A Execution Key to Equity Story
Premium
Ratings
Sanofi: Balanced Risk-Reward as Pipeline Setbacks and Dupixent LOE Temper Growth Outlook, With BD/M&A Execution Key to Equity Story
1M ago
SNY
More DE:SNW2 News >

SNW2 News on the Web

Sanofi, Regeneron Expand Immunology Alliance In Deal Worth Up To $8 Bln
rttnews
Bullish
Sanofi Strikes Strategic Deal With Cheplapharm to Hand Over 20 Mature Medicines and Three Plants
TipRanks News
Neutral
Sanofi SA at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
RBC Capital Keeps Their Hold Rating on Sanofi (SNYNF)
TipRanks News
Bullish
Deutsche Bank Sticks to Its Buy Rating for Sanofi (SNYNF)
TipRanks News
Bullish
RBC Capital Initiates a Hold Rating on Sanofi (SNYNF)
TipRanks News
Neutral
Bank of America Securities Remains a Hold on Sanofi (SNYNF)
TipRanks News
Neutral
Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B Deal
Zacks
Neutral

News Score - Last 7 Days

Neutral
DE:SNW2
Sector Average
Media Buzz
This Week4 articles
Weekly Average9.25 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:SNW2’s Media Buzz Sentiment?
4 articles about DE:SNW2 were published this week. In an average week, 9.25 articles are published.
    What is DE:SNW2’s weekly average amount of articles?
    In an average week, 9.25 articles about DE:SNW2 are published.
      What is DE:SNW2’s News Sentiment?
      50% of articles about DE:SNW2 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XENEXenon
        ABTAbbott Laboratories
        BBIOBridgeBio Pharma
        BDXBecton Dickinson
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week